Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inferring gene expression from cell-free DNA fragmentation profiles
Mohammad Shahrokh Esfahani, Emily G. Hamilton, Mahya Mehrmohamadi, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 4, pp. 585-597
Open Access | Times Cited: 125

Showing 26-50 of 125 citing articles:

Leveraging physiology and artificial intelligence to deliver advancements in health care
Angela Zhang, Zhenqin Wu, Eric Q. Wu, et al.
Physiological Reviews (2023) Vol. 103, Iss. 4, pp. 2423-2450
Closed Access | Times Cited: 17
Potential non-invasive biomarkers in tumor immune checkpoint inhibitor therapy: response and prognosis prediction
Ruixia Song, Fengsen Liu, Yu Ping, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 17
Quantitative PET-based biomarkers in lymphoma: getting ready for primetime
Juan Pablo Alderuccio, Russ Kuker, Fei Yang, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 640-657
Closed Access | Times Cited: 15
The landscape of cell-free mitochondrial DNA in liquid biopsy for cancer detection
Ymke van der Pol, Norbert Moldován, Jip Ramaker, et al.
Genome biology (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 15
A Novel Framework for Epileptic Seizure Detection Using Electroencephalogram Signals Based on the Bat Feature Selection Algorithm
Mahrad Pouryosef, Roozbeh Abedini‐Nassab, Seyed Mohammad Reza Akrami
Neuroscience (2024) Vol. 541, pp. 35-49
Closed Access | Times Cited: 5
The ALT pathway generates telomere fusions that can be detected in the blood of cancer patients
Francesc Muyas, Manuel J. Gómez, Rita Cascão, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Circulating cell-free DNA-based multi-cancer early detection
Kai Zhang, Ruiqing Fu, Rui Liu, et al.
Trends in cancer (2023) Vol. 10, Iss. 2, pp. 161-174
Open Access | Times Cited: 12
Cancer Bioenergetics and Tumor Microenvironments—Enhancing Chemotherapeutics and Targeting Resistant Niches through Nanosystems
Aisha Farhana, Abdullah Alsrhani, Yusuf S. Khan, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3836-3836
Open Access | Times Cited: 11
Circulating cell-free DNA fragmentation is a stepwise and conserved process linked to apoptosis
Dandan Zhu, Haihong Wang, Wei Wu, et al.
BMC Biology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 11
Transcriptomic Profiling of Plasma Extracellular Vesicles Enables Reliable Annotation of the Cancer-Specific Transcriptome and Molecular Subtype
Vahid Bahrambeigi, Jaewon J. Lee, Vittorio Branchi, et al.
Cancer Research (2024) Vol. 84, Iss. 10, pp. 1719-1732
Open Access | Times Cited: 4
Tissue informative cell-free DNA methylation sites in amyotrophic lateral sclerosis
Christa Caggiano, Marco Morselli, Xia Qian, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
DNA methylation and gene expression as determinants of genome-wide cell-free DNA fragmentation
Michaël Noë, Dimitrios Mathios, Akshaya V. Annapragada, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Genetic Profiling in Diffuse Large B-Cell Lymphoma: The Promise and the Challenge
Natasha H. Cutmore, Joanna A. Krupka, Daniel J. Hodson
Modern Pathology (2023) Vol. 36, Iss. 1, pp. 100007-100007
Open Access | Times Cited: 10
Cell‐free chromatin immunoprecipitation can determine tumor gene expression in lung cancer patients
Christoffer Trier Maansson, Peter Meldgaard, Magnus Stougaard, et al.
Molecular Oncology (2023) Vol. 17, Iss. 5, pp. 722-736
Open Access | Times Cited: 10
Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma: from Bench to Bedside?
Hua‐Jay J. Cherng, Alex F. Herrera
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 5, pp. 659-678
Closed Access | Times Cited: 3
Epigenetic liquid biopsies: a novel putative biomarker in immunology and inflammation
Ilana Fox-Fisher, Ruth Shemer, Yuval Dor
Trends in Immunology (2023) Vol. 44, Iss. 5, pp. 356-364
Closed Access | Times Cited: 9
Ultra-short cell-free DNA fragments enhance cancer early detection in a multi-analyte blood test combining mutation, protein and fragmentomics
Fenfen Wang, Xinxing Li, Mengxing Li, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2023) Vol. 62, Iss. 1, pp. 168-177
Closed Access | Times Cited: 9
Biological heterogeneity in diffuse large B-cell lymphoma
Laura K. Hilton, David W. Scott, Ryan D. Morin
Seminars in Hematology (2023) Vol. 60, Iss. 5, pp. 267-276
Open Access | Times Cited: 9
Clinical application of liquid biopsy based on circulating tumor DNA in non-small cell lung cancer
Xin Liu, Yue Yang, Ren Zihan, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 8
Cancer signature ensemble integrating cfDNA methylation, copy number, and fragmentation facilitates multi-cancer early detection
Su Yeon Kim, Seongmun Jeong, Wookjae Lee, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 11, pp. 2445-2460
Open Access | Times Cited: 8
Integration of Cell-Free DNA End Motifs and Fragment Lengths Can Identify Active Genes in Liquid Biopsies
Christoffer Trier Maansson, Louise Skov Thomsen, Peter Meldgaard, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1243-1243
Open Access | Times Cited: 2
Turning the tide in aggressive lymphoma: liquid biopsy for risk-adapted treatment strategies
Steven Wang, Florent Moulière, D. Michiel Pegtel, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 7, pp. 660-672
Closed Access | Times Cited: 2
Unlocking the future of cancer diagnosis – promises and challenges of ctDNA-based liquid biopsies in non-small cell lung cancer
Chiara Reina, Berina Šabanović, Chiara Lazzari, et al.
Translational research (2024) Vol. 272, pp. 41-53
Closed Access | Times Cited: 2
Prospects for liquid biopsy approaches in lymphomas
Esraa Jamal, Edward Poynton, Mohamed Elbogdady, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024), pp. 1-11
Open Access | Times Cited: 2
Cell-free and extrachromosomal DNA profiling of small cell lung cancer
Roya Behrouzi, Alexandra Clipson, Kathryn Simpson, et al.
Trends in Molecular Medicine (2024)
Open Access | Times Cited: 2

Scroll to top